Nebivolol Benzylated impurity

Nebivolol Benzylated impurity is a structurally modified derivative of the parent β-blocker, featuring benzyl groups appended to the 3-amino and 4-hydroxy functionalities of the 1H-indazol-4-yl core. This impurity arises via alkylation of the primary amine and phenolic hydroxyl, introducing methylenebenzene moieties that alter steric and electronic properties. The compound retains the 4-fluoro-3-(4-isopropylpiperidin-1-yl)phenol scaffold of nebivolol but exhibits enhanced lipophilicity due to benzyl ether and amine linkages. It serves as an HPLC reference standard for quantifying benzylated degradation byproducts in nebivolol active pharmaceutical ingredient (API) batches.